SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D. [Yahoo! Finance]
Omega Therapeutics, Inc. (OMGA)
Company Research
Source: Yahoo! Finance
next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors, today announced the appointment of Roger Sawhney, M.D. to its Board of Directors. Dr. Sawhney brings nearly 30 years of financial and strategic expertise spanning the biopharma industry. “We are thrilled to welcome Roger to our team. He is a seasoned veteran that brings a wealth of industry experience ranging from corporate strategy in the biopharma industry to healthcare investing. His expertise in cell therapy will be particularly valuable to SIRPant as we advance SIRPant-M™, our lead product candidate, into clinical development,” said Robert Towarnicki, President & CEO of SIRPant. “Roger adds a broad skill set to our Board and we look forward to benefitting from his strategic insight.” “It's an exciting and transformational time to be joining SIRPant, with two Investigational New Drug (IND) applications cleared in 2023 for SIRPant-M,” said Dr. Sawhney. “I look forw
Show less
Read more
Impact Snapshot
Event Time:
OMGA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMGA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMGA alerts
High impacting Omega Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
OMGA
News
- Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]Yahoo! Finance
- Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingGlobeNewswire
- CVAC, SBNY and CRMD are among after hour movers [Seeking Alpha]Seeking Alpha
- Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]Yahoo! Finance
OMGA
Earnings
- 3/28/24 - Beat
OMGA
Analyst Actions
- 4/1/24 - Chardan Capital
OMGA
Sec Filings
- 4/19/24 - Form PRE
- 4/16/24 - Form 8-K
- 3/28/24 - Form 10-K
- OMGA's page on the SEC website